About this episode

Dhineli Perera discusses the benefits and risks of sodium valproate with neurologist Dan McLaughlin, focusing on its implications for people of childbearing potential.

Dhineli Perera talks to neurologist Dan McLaughlin about the benefits and risks with sodium valproate, especially in people of childbearing potential. Dan outlines the evolving landscape of valproate prescribing in Australia, its adverse effects, and recent controversies surrounding potential teratogenesis linked to paternal use. Read the full article in Australian Prescriber.

People in this episode

Host: Dhineli Perera

Guest: Dan McLaughlin

Topics covered

• sodium valproate
• benefits and risks
• teratogenesis
• neurology
• prescribing practices

Keywords

• sodium valproate
• neurologist
• teratogenesis
• prescribing
• adverse effects

Mentioned in this episode

Organizations: Australian Prescriber

Products: sodium valproate

Places: Australia

More episodes of Australian Prescriber Podcast

• E218 - Diagnosis and management of irritable bowel syndrome · July 6, 2026 · 29 min
• E217 - Emergency contraception: an overview · June 22, 2026 · 19 min
• E216 - Cardiovascular-kidney-metabolic (CKM) syndrome · June 8, 2026 · 18 min
• E215 - Vitamin B12 deficiency: testing and treatment · May 25, 2026 · 21 min
• E214 - Therapeutic Guidelines Kidney and Urinary · May 11, 2026 · 19 min

Explore listener stats, chart rankings, contacts and more on the Australian Prescriber Podcast podcast page.